More evidence our cancel trials will have success
Post# of 148190
(Total Views: 472)
Posted On: 01/29/2021 12:28:59 PM
More evidence our cancel trials will have success . Check out NK news on their IL-15 antagonist combo study for NSCLC. . Nantkwest is a stock I follow for a few years . LL is a multi inflammatory antagonistic drug that hits so many markers . I’m super hopeful . Please c-suite don’t screw it up I do believe they have improved since my time here , about a year . Does anyone else follow NK . The maker of so called natural killer cells . Maybe LL should go by Natural inflammation killer .
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼